These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21109706)

  • 1. [The role of the glutamatergic system in the pathogenesis and treatment of alcohol dependence].
    Łukasik K; Piątkowska K; Pietrzak B
    Postepy Hig Med Dosw (Online); 2010 Oct; 64():534-43. PubMed ID: 21109706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Bochenski M
    Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.
    Kiefer F; Jahn H; Otte C; Demiralay C; Wolf K; Wiedemann K
    J Psychiatr Res; 2005 Sep; 39(5):545-51. PubMed ID: 15992564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical pharmacology of alcohol dependence.
    Tambour S; Quertemont E
    Fundam Clin Pharmacol; 2007 Feb; 21(1):9-28. PubMed ID: 17227441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acamprosate: recent findings and future research directions.
    Mann K; Kiefer F; Spanagel R; Littleton J
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1105-10. PubMed ID: 18540918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological treatment options for prevention of alcohol relapse].
    Heberlein A; Bleich S; Kornhuber J; Hillemacher T
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):421-8. PubMed ID: 18604776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of the glutamatergic system in alcohol addiction].
    Spanagel R
    Fortschr Neurol Psychiatr; 2003 Jul; 71 Suppl 1():S33-5. PubMed ID: 12947541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug adjuncts for treating alcohol dependence.
    Collins GB; McAllister MS; Adury K
    Cleve Clin J Med; 2006 Jul; 73(7):641-4, 647-8, 650-1, passim. PubMed ID: 16845975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiology and treatment in alcoholism--recent findings regarding Lesch's typology of alcohol dependence.
    Hillemacher T; Bleich S
    Alcohol Alcohol; 2008; 43(3):341-6. PubMed ID: 18339813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    Expert Opin Drug Saf; 2010 Jan; 9(1):177-88. PubMed ID: 20021295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medications for treating alcohol dependence.
    Williams SH
    Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gap.
    Shea CW
    South Med J; 2008 Feb; 101(2):179-85. PubMed ID: 18364621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.